<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05095753</url>
  </required_header>
  <id_info>
    <org_study_id>120190480</org_study_id>
    <nct_id>NCT05095753</nct_id>
  </id_info>
  <brief_title>Data Collection of Heart Rate and Blood Pressure</brief_title>
  <official_title>Data Collection of Heart Rate and Blood Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MindMics Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MindMics Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is data collection for building and validating the algorithms for&#xD;
      analytics of vital signs using wearable earphones (MindMics device).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MindMics is developing technology to enhance an individual's quality of life by continuously&#xD;
      monitoring the heart rate, stress thereby allowing people to make better decisions regarding&#xD;
      their health. MindMics has a working prototype of the ear buds which will perform all the&#xD;
      conventional tasks earbuds do (listen to music, etc.), but, in addition, will measure your&#xD;
      vital signs. The earbuds capture the sounds made by the various cardiac structures pulsing&#xD;
      and moving blood.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2019</start_date>
  <completion_date type="Anticipated">November 14, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 14, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>RR Interval from ECG signal</measure>
    <time_frame>20 minutes</time_frame>
    <description>Time in milliseconds between successive ECG R peaks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inter-beat Interval from earbud signal</measure>
    <time_frame>20 minutes</time_frame>
    <description>Time in milliseconds between successive peaks in earbud signal</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Systolic and diastolic blood pressure from blood pressure cuff</measure>
    <time_frame>20 minutes</time_frame>
    <description>Value of blood pressure in mmHg reported by a blood pressure cuff</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Healthy People</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Earbud</intervention_name>
    <description>In ear headphone with embedded infrasonic hemodynography technology</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy cohort&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ages 18-90&#xD;
&#xD;
          -  No gender restrictions&#xD;
&#xD;
          -  Cognitive ability to consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with pacemakers&#xD;
&#xD;
          -  Patients with irregular heart rhythms&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Anna Barnacka</last_name>
    <phone>857 210 9181</phone>
    <email>anna.barnacka@mindmics.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>maureen coyle</last_name>
    <phone>9787012626</phone>
    <email>maureen.coyle@mindmics.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>MindMics, Inc.</name>
      <address>
        <city>Cambridge</city>
        <state>Massachusetts</state>
        <zip>02140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Barnacka, PhD</last_name>
      <phone>857-210-9181</phone>
      <email>anna.barnacka@mindmics.com</email>
    </contact>
    <contact_backup>
      <last_name>maureen coyle</last_name>
      <phone>9787012626</phone>
      <email>maureen.coyle@mindmics.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 7, 2021</study_first_submitted>
  <study_first_submitted_qc>October 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2021</study_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

